FDA blesses first Boniva generics; 9 hurt in Teva factory fire in Croatia;

@FiercePharma: Antioxidants may not help people with Alzheimer's. Article via @Reuters | Follow @FiercePharma

> The FDA has approved the first generic versions of Roche's ($RHHBY) Boniva (ibandronate) tablets, a once-monthly product to treat or prevent osteoporosis in women after menopause. Apotex, Orchid Healthcare and Mylan Pharmaceuticals ($MYL) are the manufacturers that have gained approval to make generic 150-mg ibandronate tablets. FDA release

> Nine people were injured in a fire at the Zagreb, Croatia, factory of Teva Pharmaceutical Industries' ($TEVA) Pliva Pharmaceuticals unit. Production has been halted at the plant, which manufactures a generic version of Adderall. Story

> A Europol-coordinated operation has snared 6 individuals trying to sell fake drugs, including Viagra and Cialis. Almost 300,000 doses of fake medication have been seized. Europol release

> Novartis Pharmaceuticals ($NVS) said yesterday that once-daily Arcapta Neohaler (indacaterol inhalation powder) 75 mcg is now available in the U.S. for COPD patients. Novartis release

> Taro Pharmaceutical Industries has been authorized for listing on the New York Stock Exchange. The company's ordinary shares are expected to begin trading March 22, under the symbol "TARO." Taro release

> A drug shortage affecting surgery for humans could soon affect their animal companions as well. Canadian vets are monitoring drug supplies because of a shortage caused when Sandoz cut production of injectable painkillers and anesthetics. Item

Biotech News

@FierceBiotech: Frog skin secretions: icky but potent new anti-bacterials? Story | Follow @FierceBiotech

@JohnCFierce: Virtual is beautiful in biotech. Piece | Follow @JohnCFierce

@RyanMFierce: U.K. researchers are forging ahead with a pioneering trial for gene therapy to treat cystic fibrosis. News | Follow @RyanMFierce

@FierceMedDev: Japan's scandal-hit Olympus to launch new medical devices. More via @Reuters | Follow @FierceMedDev

> Shire snaps up CNS program from startup Heptares, commits $190M in 'biobucks.' Article

> Final PhIII results wipe out AstraZeneca, Targacept depression drug. News

Manufacturing News

> Sandoz's role in Canadian drug shortages adds to calls for regulation. More

> FDA says APP ignored consumer complaints for 18 months. Story

> Apotex says FDA import ban, delays 'decimated' its business. Item

Biotech Research News

> Mayo Clinic concocts skin cancer vaccine using virus, melanoma DNA. Article

> Ban on animal importation puts U.K. research at risk. Item

> Latest anti-RAGE compound defeats Alzheimer's symptoms in mice. Story

> RNAi, smuggled in a virus, weakens tumors before final radiation blow. More

> Columbia University team re-creates full human immune system in mice. Story

And Finally... Good news, oenophiles! Antioxidants in red wine, fruits and vegetables kill cancer cells, including those resistant to treatment. Scientists hope this discovery could lead to more effective tumor fighters. News

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.